ArticlePLoS computational biology2026
PHA synthase variant design using a conditional variational autoencoder.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polyhydroxyalkanoate (PHA) synthases are a group of complex, dimeric enzymes which catalyze polymerization of R-hydroxyacids into PHAs. PHA properties depend on their monomer composition but enzymes found in nature have limited specificities to certain R-hydroxyacids only. In this study, a conditional variational autoencoder was used for the first time to design novel PHA synthases. The model was trained with native protein sequences obtained from Uniprot and was used for the creation of approximately 10 000 new PHA synthase enzymes. Out of these, 16 sequences were selected for in vivo validation. The selection criteria included the presence of conserved residues such as catalytic amino acids and amino acids in the dimer interface and structural features like the number of [Formula: see text]-helices in the N-terminal part of the enzyme. Two of the 16 novel PHA synthases that had substantial numbers of amino acid substitutions (87 and 98) with respect to the most similar native enzymes were confirmed active and produced poly(hydroxybutyrate) (PHB) when expressed in yeast S. cerevisiae. The results show the power of AI based methods to create active variants of highly complex dimer enzymes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.